Skip to main content
Clinical Trials/NL-OMON43864
NL-OMON43864
Recruiting
Not Applicable

18F-FDG PET/CT versus CT imaging in staging of primary Muscle Invasive Bladder Cancer - MIBC PETCT

eids Universitair Medisch Centrum0 sites120 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
bladder cancer
Sponsor
eids Universitair Medisch Centrum
Enrollment
120
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \-All patients with a clinical diagnosis of muscle invasive bladder cancer with active disease identified within the bladder at the time of consent and imaging.
  • \-Patients with primary resectable tumour in the bladder, clinically suspect of invasive bladder carcinoma, who are potential candidates for radical cystectomy plus lymphadenectomy, will be eligible with residual disease in the bladder at the time of imaging.
  • \-All patients will have consented to diagnostic imaging procedures.

Exclusion Criteria

  • \- Prior biopsy of the primary bladder tumour within 6 months before PET/CT imaging
  • \- Prior BCG instillations.
  • \- Treatment with bladder instillations other than with BCG less than 6 months ago
  • \- Patients with sarcoidosis, tuberculosis and/or lymphatic disorders
  • \* Prior pelvic radiation for bladder cancer
  • \- Patients deemed not appropriate surgical candidates
  • \- Patients that cannot tolerate being in the PET scanner or deemed unable to receive a contrast enhanced CT.
  • \- Patients who are pregnant or lactating

Outcomes

Primary Outcomes

Not specified

Similar Trials